Cite
A single-center pilot study in Malaysia on the clinical utility of whole-exome sequencing for inborn errors of immunity.
MLA
Ripen, Adiratna Mat, et al. “A Single-Center Pilot Study in Malaysia on the Clinical Utility of Whole-Exome Sequencing for Inborn Errors of Immunity.” Clinical and Experimental Immunology, vol. 206, no. 2, Nov. 2021, pp. 119–28. EBSCOhost, https://doi.org/10.1111/cei.13626.
APA
Ripen, A. M., Chear, C. T., Baharin, M. F., Nallusamy, R., Chan, K. C., Kassim, A., Choo, C. M., Wong, K. J., Fong, S. M., Tan, K. K., Nachiappan, J. P., Teo, K. R., Chiow, M. Y., Hishamshah, M., Ghani, H., Muralitharan, R. R., & Mohamad, S. B. (2021). A single-center pilot study in Malaysia on the clinical utility of whole-exome sequencing for inborn errors of immunity. Clinical and Experimental Immunology, 206(2), 119–128. https://doi.org/10.1111/cei.13626
Chicago
Ripen, Adiratna Mat, Chai Teng Chear, Mohd Farid Baharin, Revathy Nallusamy, Kwai Cheng Chan, Asiah Kassim, Chong Ming Choo, et al. 2021. “A Single-Center Pilot Study in Malaysia on the Clinical Utility of Whole-Exome Sequencing for Inborn Errors of Immunity.” Clinical and Experimental Immunology 206 (2): 119–28. doi:10.1111/cei.13626.